EVA: Evaluation of EVOKE Therapy Metrics Generated Using the Evoke System With EVA

NCT07267715 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-12-05

No results posted yet for this study

Summary

The Evoke Spinal Cord Stimulator (SCS) System (Evoke® System) is an FDA-approved device that is used to manage long lasting, severe pain that is not relieved by typical medical treatments.

This research registry is being conducted to collect data from patients treated with a SCS device in order to determine how the device impacts their chronic pain condition.

Specifically, the study aims to:

* Evaluate data collected from the SCS system on how well the system is working.
* Evaluate the feasibility of programming the SCS system independently without external assistance.
* Evaluate changes in physical function, fatigue, pain interference, mood, sleep, daily activities, pain control, and overall satisfaction with the device.

Conditions

Interventions

DEVICE

Spinal Cord Stimulation (SCS) System

Spinal cord stimulation system as an aid in the management of chronic intractable pain of the trunk and/or limbs; and will be used within its commercially approved indication.

Sponsors & Collaborators

  • Saluda Medical Pty Ltd

    collaborator INDUSTRY
  • Dustin Reynolds, MD

    lead OTHER

Principal Investigators

  • Dustin Reynolds, MD · Mount Carmel Health System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-30
Primary Completion
2026-11-01
Completion
2026-11-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07267715 on ClinicalTrials.gov